Silexion Therapeutics (SLXNW) Stock Price, News & Analysis
Company Description
Silexion Therapeutics (NASDAQ: SLXNW) is a publicly traded company in the Biological Products, (no Diagnostic Substances) sector.
SLXNW stock has declined 41.2% over the past year. Shares last traded at $0.0250.
On a trailing twelve-month basis, Silexion Therapeutics reported revenue of $155K with net income of -$11.9M and diluted earnings per share of $8.96. The company operates at a net profit margin of -7685.2%.
This page provides a comprehensive overview of SLXNW stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Silexion Therapeutics (SLXNW) stock last traded at $0.0250, down 16.11% from the previous close. Over the past 12 months, the stock has lost 41.2%.
SLXNW Rankings
Latest News
SEC Filings
Silexion Therapeutics has filed 5 recent SEC filings, including 2 Form 4, 1 Form SCHEDULE 13D/A, 1 Form DEF 14A, 1 Form S-3. The most recent filing was submitted on June 23, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all SLXNW SEC filings →
Financial Highlights
Silexion Therapeutics generated $155K in revenue over the trailing twelve months, operating income reached -$11.6M (-7504.5% operating margin), and net income was -$11.9M, reflecting a -7685.2% net profit margin. Diluted earnings per share stood at $8.96. The company generated -$10.8M in operating cash flow. With a current ratio of 2.41, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Silexion Therapeutics (SLXNW) currently stands at 5.5 thousand shares. Over the past 12 months, short interest has decreased by 52.8%.
Days to Cover History
Days to cover for Silexion Therapeutics (SLXNW) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 1.6 days.
SLXNW Company Profile & Sector Positioning
Silexion Therapeutics (SLXNW) operates in the Biological Products, (no Diagnostic Substances) sector and is listed on the NASDAQ.